Cross Country Healthcare schedules July 16 shareholder vote on merger; supplemental proxy disclosures
Cross Country Healthcare has scheduled a special meeting for July 16, 2026, for shareholders to vote on a merger with KL Criss Cross entities. The company expects the merger to close in Q3 2026, pending shareholder approval. Despite two shareholder lawsuits alleging disclosure deficiencies, the company denies the claims and has voluntarily supplemented the proxy with additional details.
[8-K] CROSS COUNTRY HEALTHCARE INC Reports Material Event
Cross Country Healthcare Inc. (CCRN) filed an 8-K report detailing material events related to its proposed merger with KL Criss Cross Intermediate, LLC. The report primarily addresses recent litigation and demands from purported shareholders alleging deficiencies in the previously filed proxy statement for the merger. In response, the company has voluntarily supplemented the proxy statement with additional disclosures to address these concerns, despite believing the claims are without merit.
Enterprise value to EBIT forward of Cross Country Healthcare, Inc. – GETTEX:XXY
This article focuses on the "Enterprise value to EBIT forward" metric for Cross Country Healthcare, Inc. (GETTEX:XXY). It presents this financial data point within the context of the company's financial overview on a trading platform, indicating its relevance for investors analyzing the company's valuation.
Price to book forward of Cross Country Healthcare, Inc. – NASDAQ:CCRN
This article provides financial information for Cross Country Healthcare, Inc. (NASDAQ: CCRN), specifically focusing on its price-to-book forward metric. It details the stock's market status, financial data availability, and references various data providers like ICE Data Services and FactSet. The page itself appears to be a financial data portal displaying key metrics for the company.
(CCRN) Movement Within Algorithmic Entry Frameworks
Cross Country Healthcare Inc. (NASDAQ: CCRN) shows stable neutral readings in shorter horizons, potentially indicating an easing of a long-term weak bias. No clear price positioning or resistance levels above the current price are identified, suggesting upside potential. The article provides detailed institutional trading strategies with specific entry zones, targets, and stop losses for position trading, momentum breakout, and risk hedging.
Enterprise value to revenue forward of Cross Country Healthcare, Inc. – NASDAQ:CCRN
The article presents information about Cross Country Healthcare, Inc. (NASDAQ:CCRN) focusing on its enterprise value to revenue forward metric. It appears to be a financial data snippet from TradingView, indicating the stock symbol, market, and a general overview of available financial information.
CCRN Forecast — Price Target — Prediction for 2027
This article provides a forecast and price target for Cross Country Healthcare, Inc. (CCRN) stock, based on analyst opinions. It details current stock performance, historical highs and lows, volatility, market capitalization, and upcoming earnings information. The report also addresses common questions about the company's financials and stock trading.
Cross Country Healthcare merger moves forward as antitrust waiting period ends By Investing.com
Cross Country Healthcare announced that the antitrust waiting period for its merger with KL Criss Cross Intermediate, LLC has expired, a key step towards completing the transaction, which also includes the sale of its locums business. The merger is expected to close in the third quarter of 2026, and a shareholder meeting to vote on the proposal is scheduled for July 16, 2026. InvestingPro analysis suggests the company is undervalued and holds more cash than debt.
HSR clearance advances Cross Country Healthcare (CCRN) merger and locums sale
Cross Country Healthcare (CCRN) has cleared a significant regulatory step for its proposed merger with KL Criss Cross Intermediate, LLC and the sale of its locums business, with the Hart-Scott-Rodino waiting periods expiring on June 22, 2026. This removes a major antitrust hurdle, although the transactions are still subject to other customary closing conditions, including a shareholder vote scheduled for July 16, 2026. The merger is anticipated to close in the third quarter of 2026.
Cross Country Healthcare Inc (CCRN) Financial Health: Profitability & Balance Sheet Analysis
Cross Country Healthcare Inc (CCRN) currently has a financial score of 7.15, ranking 91 out of 161 in its industry, indicating a robust financial status though its operating efficiency is average. While its latest quarterly revenue saw a 17.84% year-over-year decrease to $241.06M, its net profit experienced a significant 770.61% year-over-year decrease. The company's stock price is $13.199, showing a slight increase of 0.22%.
Cross Country Healthcare Inc (CCRN) Technical Analysis: Support, Resistance, Indicators & Moving Averages
This article provides a technical analysis of Cross Country Healthcare Inc (CCRN), highlighting its current price momentum score, support and resistance levels, and indicator readings. It details various technical indicators like MACD, RSI, and Moving Averages, offering buy, sell, or neutral signals. The analysis suggests a "Buy" signal based on moving averages and other technical indicators for CCRN.
Cross Country Healthcare Inc (CCRN) Shareholder Structure: Major Shareholders & Institutional Holdings
This article provides a detailed breakdown of Cross Country Healthcare Inc's (CCRN) shareholder structure, listing major shareholders and categorizing them by type. It also includes institutional shareholding trends over recent quarters and highlights significant shareholder activity. Finally, it notes various ETFs that hold CCRN, showing the stock's presence in broader investment products.
Cross Country Healthcare Inc (CCRN) Valuation: PE, PB & Fair Value Analysis
This article provides a valuation analysis of Cross Country Healthcare Inc (CCRN), noting its current valuation score is 8.79, ranking 61st in its industry. It highlights the company's current P/E ratio of -4.32, which is significantly below its recent high and above its recent low. The article also mentions that relevant data for P/B, P/S, and P/CF ratios have not yet been disclosed by the company.
Cross Country Healthcare Inc (CCRN) Earnings Forecast: Future EPS & Revenue Growth Estimates
Cross Country Healthcare Inc (CCRN) has an earnings forecast score of 6.00, placing it 124th in the Professional & Commercial Services industry. Analysts have an average price target of $11.00 for CCRN, with a "Hold" rating based on the consensus of 9 analysts. The company's expected revenue for the next quarter is $242.85 million.
Cross Country Healthcare (NASDAQ: CCRN) agrees to $13.25 cash takeover
Cross Country Healthcare (NASDAQ: CCRN) has agreed to be acquired by an affiliate of Knox Lane for $13.25 per share in cash, representing a 31% premium to its closing price on May 6, 2026. The merger, valued at $437 million, is subject to stockholder approval and regulatory clearances, including HSR review, with an expected close in Q3 2026. Cross Country's board has unanimously recommended stockholders vote "FOR" the merger at a special virtual meeting scheduled for July 16, 2026.
Trading Systems Reacting to (CCRN) Volatility
This article analyzes Cross Country Healthcare Inc. (CCRN) using AI models, identifying neutral sentiment in shorter horizons but a weak long-term bias. It provides three distinct trading strategies—Position, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss levels. The analysis also highlights key support and resistance signals across different time horizons.
Cross Country Healthcare Price Target Maintained With a $13.25/Share by Barrington Research
Barrington Research has maintained its price target for Cross Country Healthcare (NASDAQ: CCRN) at $13.25 per share. This indicates a continued positive outlook on the company's valuation by the research firm. Investors may use this information to assess the potential future performance of CCRN stock.
Knox Lane to acquire Cross Country Healthcare for $437 million By Investing.com
Knox Lane, a San Francisco-based investment firm, announced its plan to acquire Cross Country Healthcare Inc. for $437 million in an all-cash transaction. The deal, valued at $13.25 per share, represents a significant premium over the company's recent trading prices. Cross Country Healthcare, a healthcare workforce solutions company, will become a privately held entity under Knox Lane, continuing to operate under its existing name, with the acquisition expected to close in the third quarter of 2026.
Cross Country Healthcare (CCRN) price target decreased by 21.96% to 11.68
This article reports a significant 21.96% reduction in the price target for Cross Country Healthcare (CCRN) to $11.68. This adjustment reflects a downward revision in analysts' expectations for the company's future stock performance.
How Cross Country Healthcare Inc. (CCRN) Affects Rotational Strategy Timing
This article analyzes Cross Country Healthcare Inc. (CCRN) through a rotational strategy lens, identifying mixed sentiment and a lack of clear price positioning. It presents AI-generated trading strategies for different risk profiles, including long, breakout, and short positions, along with multi-timeframe signal analysis. The report highlights compelling upside potential due to the absence of resistance levels above the current price.
How Cross Country Healthcare Inc. (CCRN) Affects Rotational Strategy Timing
Quantitative Research Desk provides an analysis of Cross Country Healthcare Inc. (CCRN) focusing on its impact on rotational strategy timing. The analysis shows mixed market sentiment and no clear price positioning, with significant upside potential due to the absence of resistance levels above the current price. It offers three distinct AI-generated trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—tailored for different risk profiles and holding periods, along with multi-timeframe signal analysis.
Wedbush downgrades Cross Country Healthcare (CCRN)
Wedbush has downgraded Cross Country Healthcare (CCRN). The article information is minimal, indicating only the downgrade by Wedbush. Further details are not provided in the snippet.
Cross Country Healthcare, Inc. - Common Stock (NQ: CCRN)
This article provides a compilation of recent news headlines, press releases, and research reports related to Cross Country Healthcare, Inc. (Nasdaq: CCRN). It covers various announcements including asset acquisitions, industry surveys, investor events, stock repurchase programs, financial results, marketing awards, and analyst ratings. The news items span from June 2022 to September 2022, highlighting the company's activities and market performance during that period.
Cross Country Healthcare to be Acquired by Knox Lane in All-Cash Transaction Valued at $437 Million
Cross Country Healthcare, a leading technology-driven healthcare workforce solutions company, announced it will be acquired by Knox Lane in an all-cash transaction valued at $437 million. Stockholders will receive $13.25 per share, representing impressive premiums over recent trading prices. The acquisition is expected to close in Q3 2026, with Cross Country Healthcare continuing to operate under its existing brand as a privately held company in Knox Lane's portfolio.
CCRN Investors Have Opportunity to Join Cross Country Healthcare, Inc. Fraud Investigation with ...
The Schall Law Firm has announced an investigation into Cross Country Healthcare, Inc. (NASDAQ: CCRN) for potential securities law violations. The investigation centers on whether the company made false or misleading statements and/or failed to disclose critical information to investors. Shareholders who suffered losses are encouraged to contact the firm to discuss their rights.
CCRN Investors Have Opportunity to Join Cross Country Healthcare, Inc. Fraud Investigation with the Schall Law Firm
The Schall Law Firm has announced an investigation into Cross Country Healthcare, Inc. (NASDAQ: CCRN) on behalf of investors. The firm is looking into potential violations of securities laws, specifically whether the company made false or misleading statements or failed to disclose crucial information. Shareholders who have suffered losses are encouraged to participate in the investigation.
CCRN Investors Have Opportunity to Join Cross Country Healthcare, Inc. Fraud Investigation with the Schall Law Firm
The Schall Law Firm is investigating Cross Country Healthcare, Inc. (NASDAQ: CCRN) for potential securities law violations, focusing on whether the company made false or misleading statements to investors. Shareholders who have incurred losses are encouraged to participate in the investigation by contacting the firm for a free consultation. The Schall Law Firm specializes in securities class action lawsuits and shareholder rights litigation.
CCRN Investors Have Opportunity to Join Cross Country Healthcare, Inc. Fraud Investigation with the Schall Law Firm
The Schall Law Firm is investigating Cross Country Healthcare, Inc. (CCRN) for potential securities law violations due to alleged false and/or misleading statements and failure to disclose pertinent information to investors. Shareholders who have suffered a loss are encouraged to contact the firm to discuss their rights and participate in the fraud investigation. The firm specializes in securities class action lawsuits and shareholder rights litigation globally.
Cross Country Healthcare and Florida Atlantic University’s Christine E. Lynn College of Nursing Release Purpose Under Pressure: The State of Nursing in 2026
Cross Country Healthcare and Florida Atlantic University's Christine E. Lynn College of Nursing released their fifth annual national nursing survey, "Purpose Under Pressure: The State of Nursing in 2026." The report, based on insights from over 2,000 nurses and nursing students, highlights nurses' deep commitment to patient care despite increasing pressures like burnout and short staffing. The study emphasizes the need for healthcare leaders to provide greater flexibility, support, and career sustainability to retain current nurses and prepare the next generation.
Cross Country Expands AI-Powered Workforce Intelligence for Health Systems Through Exclusive Optimé Solution
Cross Country Healthcare, Inc. announced an exclusive 36-month partnership to integrate the Optimé workforce strategy solution into its Intellify® platform. This integration will enhance Intellify with advanced forecasting, analytics, and workforce optimization capabilities to help health systems better manage staffing, reduce labor costs, and improve resource utilization. This partnership marks a significant step in Cross Country's evolution from a workforce solutions provider to a technology-enabled workforce partner, offering a more predictive and integrated labor strategy for the healthcare market.
Boston Partners holds 7.85% of Cross Country Healthcare (NASDAQ: CCRN)
Boston Partners has disclosed a 7.85% beneficial stake in Cross Country Healthcare (NASDAQ: CCRN), amounting to 2,538,481 shares, as of March 31, 2026. The shares are held in discretionary accounts for clients, with Boston Partners exercising sole voting and dispositive power. This Schedule 13G filing indicates a passive investment.
Cross Country Expands AI-Powered Workforce Intelligence for Health Systems Through Exclusive Optimé Solution
Cross Country Healthcare, Inc. has announced an exclusive 36-month partnership to integrate Optimé, a workforce strategy and planning solution by Strategic Systems International, into its Intellify® platform. This collaboration aims to provide health systems with advanced AI-powered forecasting, analytics, and workforce optimization capabilities to better align staffing with patient demand, improve resource utilization, and reduce labor costs. The partnership signifies Cross Country's evolution into a technology-enabled workforce partner, enhancing Intellify's ability to offer a more proactive and integrated labor strategy for healthcare.
Cross Country Expands AI-Powered Workforce Intelligence for Health Systems Through Exclusive Optimé Solution
Cross Country Healthcare has announced an exclusive 36-month partnership to integrate Strategic Systems International's Optimé solution into its Intellify workforce intelligence platform. This collaboration aims to provide health systems with advanced AI-powered forecasting and optimization capabilities to improve staffing precision, operational efficiency, and labor cost management. The Optimé solution will enhance Intellify by offering a more predictive approach to workforce management, helping health systems align staffing with patient demand and achieve better operational control.
Cross Country Healthcare partners with SSI for workforce platform
Cross Country Healthcare Inc. (NASDAQ:CCRN) has announced a 36-month exclusive partnership with Strategic Systems International to integrate Optimé workforce planning into its Intellify platform. This collaboration aims to enhance workforce optimization and reduce labor costs for health systems by aligning supply with patient demand. The partnership comes as Cross Country Healthcare's stock has seen a 62% year-to-date surge, and follows recent news of its impending acquisition by Knox Lane for $437 million.
Number of shareholders of Cross Country Healthcare, Inc. – NASDAQ:CCRN
This article provides details on the number of shareholders for Cross Country Healthcare, Inc. (NASDAQ: CCRN). It indicates the period, value, change, and percentage change related to the shareholder count. The data is provided by ICE Data Services and FactSet.
Cross Country Healthcare to Be Taken Private for $13.25 Per Share by Knox Lane Affiliate
Cross Country Healthcare (CCRN) has agreed to be acquired by an affiliate of Knox Lane for $13.25 per share in cash, taking the company private. The deal will result in Cross Country becoming a wholly owned subsidiary and being delisted from Nasdaq. The agreement includes standard closing conditions and a potential divestiture of the locums business if necessary.
Wedbush Maintains Cross Country Healthcare(CCRN.US) With Hold Rating, Maintains Target Price $13.25
Wedbush has reiterated its Hold rating on Cross Country Healthcare (CCRN.US), keeping the target price at $13.25. This indicates the firm's continued neutral stance on the company's stock performance.
Benchmark downgrades Cross Country Healthcare (CCRN)
This article reports that Benchmark has downgraded Cross Country Healthcare (CCRN). The specific details of the downgrade and any new price target are not available in this snippet. Further information would be needed to understand the implications of this rating change.
Cross Country Healthcare (CCRN) Q4 EPS Loss Deepens Challenging Profitability Turnaround Narratives
Cross Country Healthcare (CCRN) reported a Q4 2025 revenue of US$236.8 million and a basic EPS loss of US$2.56, deepening its full-year loss to US$94.9 million. Analysts forecast aggressive earnings growth of 102.9% per year based on cost efficiency and mix shifts, despite largely flat revenue projections. The company's current P/S ratio of 0.4x is significantly lower than industry averages, with a DCF fair value of US$46.81, indicating that future profitability hinges on substantial margin improvement.
CCRN Investors Have Opportunity to Join Cross Country Healthcare, Inc. Fraud Investigation with the Schall Law Firm
The Schall Law Firm has announced an investigation into Cross Country Healthcare, Inc. (NASDAQ: CCRN) for potential securities law violations. The firm is looking into whether the company made false or misleading statements and failed to disclose important information to investors. Shareholders who have suffered losses are encouraged to contact The Schall Law Firm to discuss their rights.
Cross Country Healthcare (CCRN) reports Q1 loss, beats revenue estimates
Cross Country Healthcare (CCRN) announced a Q1 loss per share of $0.09, which aligns with analyst estimates. Despite the loss, the company exceeded revenue expectations, reporting $505.7 million against an estimated $505.4 million. This indicates some resilience in its financial performance, particularly on the revenue front.
Cross Country Healthcare to be taken private by PE firm for $437M
Cross Country Healthcare, a staffing technology company, is set to be acquired by private equity firm Knox Lane in an all-cash deal valued at $437 million. This acquisition, which will take the company private, represents a 31% premium over its recent stock price. The deal follows a previously collapsed acquisition attempt by travel nursing agency Aya Healthcare due to antitrust concerns from the Federal Trade Commission.
Cross Country Healthcare to Be Acquired by Knox Lane
Cross Country Healthcare will be acquired by Knox Lane in an all-cash deal valued at approximately $437 million, or $13.25 per share. This transaction, representing a significant premium for shareholders, will take the company private and delist it from Nasdaq, with closing expected in Q3 2026 pending regulatory approvals. The acquisition aims to leverage Cross Country's AI-enabled staffing platform and healthcare relationships, while the company has canceled its earnings call and shareholder meeting to focus on the sale.
Cross Country Healthcare (NASDAQ: CCRN) posts Q1 2026 loss, agrees $13.25 cash buyout
Cross Country Healthcare (CCRN) reported a first-quarter 2026 net loss of $4.3 million on revenue of $241.1 million, a 17.8% year-over-year decrease largely due to lower volumes in both Nurse and Allied Staffing and Physician Staffing segments. Following the quarter, the company announced a definitive agreement to be acquired by KL Criss Cross Intermediate, LLC for $13.25 per share in cash, which will take the company private upon closing. Despite the loss, CCRN maintains a strong cash position of $105.6 million with no ABL borrowings, and a substantial portion of its share repurchase program remains.
Cross Country Healthcare Agrees to $437 Million Cash Buyout By Knox Lane
Cross Country Healthcare has agreed to be acquired by private equity firm Knox Lane for approximately $437 million in cash. Shareholders will receive $7.50 per share, representing a 20% premium over the closing price on Wednesday. The deal is expected to close in Q4 2024, subject to shareholder and regulatory approvals.
Cross Country: Q1 Earnings Snapshot
Cross Country Healthcare Inc. (CCRN) reported a first-quarter loss of $4.3 million, or 14 cents per share. Adjusted losses were 3 cents per share, which exceeded Wall Street expectations. The company also surpassed revenue forecasts, posting $241.1 million for the period.
Cross Country (NASDAQ: CCRN) Q1 revenue falls 18% amid pending sale
Cross Country Healthcare (CCRN) reported a Q1 2026 revenue of $241.1 million, an 18% decrease year-over-year but a 2% sequential increase, signaling stabilization after an industry slowdown. The company posted a net loss of $4.3 million and generated $3.9 million in Adjusted EBITDA. CCRN also announced a pending merger with KL Criss Cross Intermediate, after which its stock is expected to be delisted and deregistered.
Cross Country Healthcare Up Over 29%, on Pace for Largest Percent Increase Since December 2024 -- Data Talk
Cross Country Healthcare's stock price has surged over 29%, putting it on track for its largest percentage increase since December 2024. The volume of shares traded also significantly exceeded its 10-day average. The company's EPS growth in Q3 2025 was 40% year-over-year, and it is scheduled to report its next earnings on February 26, 2026.
Staffing firm Cross Country Healthcare to be acquired by Knox Lane for $437M
Cross Country Healthcare is set to be acquired by investment firm Knox Lane for $437 million, effectively taking the travel nursing company private. This deal, valued at $13.25 per share, represents a 31% premium over recent closing prices and comes after a previous $615 million merger with Aya Healthcare was called off due to regulatory concerns. Cross Country, a 40-year-old publicly traded company since 2001, will continue to operate under its existing brand.
Cross Country Healthcare stock surges on Knox Lane buyout deal
Cross Country Healthcare Inc. (NASDAQ: CCRN) shares surged 29% after announcing it will be acquired by Knox Lane, a growth-oriented investment firm, in an all-cash transaction. The deal values the company at $437 million, with shareholders receiving $13.25 per share, representing a significant premium over recent trading prices. Upon completion, expected in Q3 2026, Cross Country Healthcare will become a privately held company under the Knox Lane portfolio.
